BTAI - BioXcel Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BTAI is currently covered by 8 analysts with an average price target of $58.23. This is a potential upside of $56.26 (2855.84%) from yesterday's end of day stock price of $1.97.

BioXcel Therapeutics's activity chart (see below) currently has 83 price targets and 89 ratings on display. The stock rating distribution of BTAI is 28.57% HOLD, 67.86% BUY and 3.57% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.84% with an average time for these price targets to be met of 289.8 days.

Highest price target for BTAI is $16, Lowest price target is $4, average price target is $21.6.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 22-Jun-2025. First documented stock forecast 01-Apr-2018.

Currently out of the existing stock ratings of BTAI, 8 are a HOLD (28.57%), 19 are a BUY (67.86%), 1 are a SELL (3.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$8

$6.03 (306.09%)

21 days ago
(22-Jun-2025)

6/19 (31.58%)

$6.35 (384.85%)

564

Sell

$4

$2.03 (103.05%)

$23

6 months 7 days ago
(06-Jan-2025)

4/4 (100%)

$-3.54 (-46.95%)

378

Buy

6 months 8 days ago
(05-Jan-2025)

9/11 (81.82%)

$-52.4 (-74.43%)

446

Hold

$16

$14.03 (712.18%)

$64

11 months 2 days ago
(11-Aug-2024)

7/10 (70%)

$5.48 (52.09%)

48

Hold

$16

$14.03 (712.18%)

$56

11 months 5 days ago
(08-Aug-2024)

1/4 (25%)

$4.3 (36.75%)

280

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTAI (BioXcel Therapeutics) average time for price targets to be met?

On average it took 289.8 days on average for the stock forecasts to be realized with a an average price target met ratio 63.84

Which analyst has the current highest performing score on BTAI (BioXcel Therapeutics) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on BTAI (BioXcel Therapeutics)?

Raghuram Selvaraju works at HC WAINWRIGHT and has 3 price targets and 16 ratings on BTAI

Which analyst is the currently most bullish on BTAI (BioXcel Therapeutics)?

Do Kim with highest potential upside - $1662.03

Which analyst is the currently most reserved on BTAI (BioXcel Therapeutics)?

Sumant Kulkarni with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?